A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

August 10, 2017

Study Completion Date

August 10, 2017

Conditions
Non-Proliferative Diabetic Retinopathy
Interventions
DRUG

1.0mg Luminate®

DRUG

2.0mg Luminate®

DRUG

3.0mg Luminate®

OTHER

Balanced Salt Solution for intravitreal injection in 0.10cc

Trial Locations (12)

22031

The Retina Group of Washington, Fairfax

33805

Center for Retina and Macular Disease, Lakeland

46290

Midwest Eye Institute, Indianapolis

62704

Illinois Retina Center, Springfield

78240

Medical Center Ophthalmology Associates, San Antonio

78503

Valley Retina Institute, McAllen

78705

Austin Retina Associates, Austin

79606

Retina Research Institute Of Texas, Abilene

92868

UCI Medical Center, Orange

94040

Northern California Retina Vitreous Associates, Mountain View

99204

Spokane Eye Clinical Research, Spokane

06320

New England Retina Associates, New London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Trial Runners, LLC

OTHER

lead

Allegro Ophthalmics, LLC

INDUSTRY